Sanofi Suspends Eligard Sales Despite Stay Of Injunction
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi-Aventis is suspending U.S. sales of QLT's Eligard (leuprolide) despite a court ruling that would have allowed them to market the prostate cancer therapy